Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 6.42% |
| Q2 2025 | 74.67% |
| Q1 2025 | -11.14% |
| Q4 2024 | -31.21% |
| Q3 2024 | -6.42% |
| Q2 2024 | 97.76% |
| Q1 2024 | -38.42% |
| Q4 2023 | 14.77% |
| Q3 2023 | 4.75% |
| Q2 2023 | 18.46% |
| Q1 2023 | -31.72% |
| Q4 2022 | -4.03% |
| Q3 2022 | 56.09% |
| Q2 2022 | -13.24% |
| Q1 2022 | -58.98% |
| Q4 2021 | 36.56% |
| Q3 2021 | -47.92% |
| Q2 2021 | 178.95% |
| Q1 2021 | -2.96% |
| Q4 2020 | 36.60% |
| Q3 2020 | -2.50% |
| Q2 2020 | 43.88% |
| Q1 2020 | -21.52% |
| Q4 2019 | 18.46% |
| Q3 2019 | 245.76% |
| Q2 2019 | -58.16% |
| Q1 2019 | -44.20% |
| Q4 2018 | 37.57% |
| Q3 2018 | 7.62% |
| Q2 2018 | 15.32% |
| Q1 2018 | 174.07% |
| Q4 2017 | -55.49% |
| Q3 2017 | -0.55% |
| Q2 2017 | 55.08% |
| Q1 2017 | -2.07% |
| Q4 2016 | -4.74% |
| Q3 2016 | 34.57% |
| Q2 2016 | 8.05% |
| Q1 2016 | 16.78% |
| Q4 2015 | -26.96% |